Screener
Silexion Therapeutics SLXN Q2 2026 earnings
Reported August 14, 2026 · Before market open
EPS-$5.17Beat by $16.03
EPS estimate-$21.20
Next report
Nov 11, 2026 (in 2 months)EPS estimate-$9.10
Versus estimates
Diluted EPS
FAQ
- When did Silexion Therapeutics report Q2 2026 earnings?
- Silexion Therapeutics (SLXN) reported Q2 2026 earnings on August 14, 2026 before market open.
- What were Silexion Therapeutics's Q2 2026 revenue and EPS?
- Silexion Therapeutics reported eps of $-5.17 for Q2 2026.
- Did Silexion Therapeutics beat estimates in Q2 2026?
- EPS beat the consensus estimate of $-21.20 by $16.03.
- How did Silexion Therapeutics's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 19.7% from $-4.32.
- Where can I find Silexion Therapeutics's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001178913-26-004122) and the 10-Q periodic report (0001178913-26-004138) directly on SEC EDGAR. The filing index links above go to sec.gov.
